N-(1-(3-chlorophenyl)-2-hydroxyethyl)-3-(3-fluoro-4-hydroxyphenyl)-1H-indazole-5-carboxamide

ID: ALA3799983

Chembl Id: CHEMBL3799983

PubChem CID: 137210065

Max Phase: Preclinical

Molecular Formula: C22H17ClFN3O3

Molecular Weight: 425.85

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NC(CO)c1cccc(Cl)c1)c1ccc2[nH]nc(-c3ccc(O)c(F)c3)c2c1

Standard InChI:  InChI=1S/C22H17ClFN3O3/c23-15-3-1-2-12(8-15)19(11-28)25-22(30)14-4-6-18-16(9-14)21(27-26-18)13-5-7-20(29)17(24)10-13/h1-10,19,28-29H,11H2,(H,25,30)(H,26,27)

Standard InChI Key:  HJWORTJKQYPPQB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3799983

    ---

Associated Targets(Human)

MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 425.85Molecular Weight (Monoisotopic): 425.0942AlogP: 4.19#Rotatable Bonds: 5
Polar Surface Area: 98.24Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.87CX Basic pKa: 1.51CX LogP: 3.94CX LogD: 3.81
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.39Np Likeness Score: -1.28

References

1. Li L, Liu F, Jin N, Tang S, Chen Z, Yang X, Ding J, Geng M, Jiang L, Huang M, Cao J..  (2016)  Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2).,  26  (11): [PMID:27106711] [10.1016/j.bmcl.2016.04.029]

Source